SCHEMBL13487522

SCHEMBL13487522

CC1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4nc5ccccc5nc4-c4ccccc4)c4ccc(-c5ccccc5)cc34)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.38
KDM4E B2RXH2 7/20 0.36
L3MBTL1 Q9Y468 6/20 0.36
ALDH1A1 P00352 5/20 0.36
KMT2A Q03164 2/20 0.36
ATM Q13315 1/20 0.36
TLR9 Q9NR96 1/20 0.36
LMNA P02545 5/20 0.36
GAA P10253 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
THRB P10828 1/20 0.36
MEN1 O00255 1/20 0.35
DHODH Q02127 2/20 0.34
AKT1 P31749 1/20 0.34
AKT2 P31751 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HTT P42858 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
PIK3R1 P27986 1/20 0.33
PIK3CA P42336 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487750 0.96 TDP1 (0.36) TDP1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL13487523 0.94 ALDH1A1 (0.40) TDP1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL13487700 0.94 KDM4E (0.37) TDP1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL13487908 0.94 TDP1 (0.38) TDP1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL13488137 0.92 TDP1 (0.39) TDP1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL13487608 0.92 TDP1 (0.35) TDP1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL13487456 0.92 ALDH1A1 (0.46) TDP1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL13487814 0.90 ALDH1A1 (0.39) TDP1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL13487530 0.89 ESR1 (0.39) DHODHSMN1; SMN2PIK3CA
SCHEMBL13487687 0.89 KDM4E (0.37) TDP1KDM4EL3MBTL1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 TDP1 1904/4885KDM4E 3671/4885L3MBTL1 1193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.